Search

Your search keyword '"Riemekasten G"' showing total 91 results

Search Constraints

Start Over You searched for: "Riemekasten G" Remove constraint "Riemekasten G" Journal international journal of molecular sciences Remove constraint Journal: international journal of molecular sciences
91 results on '"Riemekasten G"'

Search Results

1. Molecular Effects of Auto-Antibodies on Angiotensin II Type 1 Receptor Signaling and Cell Proliferation.

2. Autoantibodies Targeting AT 1 - and ET A -Receptors Link Endothelial Proliferation and Coagulation via Ets-1 Transcription Factor.

3. Autoantibodies from Patients with Scleroderma Renal Crisis Promote PAR-1 Receptor Activation and IL-6 Production in Endothelial Cells.

4. Antiphospholipid Antibodies as Key Players in Systemic Lupus Erythematosus: The Relationship with Cytokines and Immune Dysregulation.

5. Unraveling the Pathogenesis of Calcinosis in Systemic Sclerosis: A Molecular and Clinical Insight.

6. Lymphocytes Change Their Phenotype and Function in Systemic Lupus Erythematosus and Lupus Nephritis.

7. Soluble Epoxide Hydrolase Inhibition Attenuates Proteinuria by Alleviating Renal Inflammation and Podocyte Injuries in Adriamycin-Induced Nephropathy.

8. New Insights and Future Perspectives of APRIL in IgA Nephropathy.

9. Dysregulated S100A9 Expression Impairs Matrix Deposition in Chronic Wounds.

10. Comprehensive Review of COVID-19: Epidemiology, Pathogenesis, Advancement in Diagnostic and Detection Techniques, and Post-Pandemic Treatment Strategies.

11. A20 in Kidney Transplantation and Autoimmunity.

12. Evaluating Single-Nucleotide Polymorphisms in Inflammasome Proteins and Serum Levels of IL-18 and IL-1β in Kidney Interstitial Damage in Anti-Neutrophilic Cytoplasmic Antibody-Associated Vasculitis.

13. Minimal Change Disease: Pathogenetic Insights from Glomerular Proteomics.

14. Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: From Bedside to Bench and Back Again.

15. Fibroblasts and Endothelial Cells in Three-Dimensional Models: A New Tool for Addressing the Pathogenesis of Systemic Sclerosis as a Prototype of Fibrotic Vasculopathies.

16. Autoantibodies Targeting G-Protein-Coupled Receptors: Pathogenetic, Clinical and Therapeutic Implications in Systemic Sclerosis.

17. Circulating Monocyte Chemoattractant Protein-1 (MCP-1) in Patients with Primary Biliary Cholangitis.

18. Lupus Nephritis Biomarkers: A Critical Review.

19. Immune Profiling of Patients with Systemic Sclerosis through Targeted Proteomic Analysis.

20. Inhibiting Intracellular α 2C -Adrenoceptor Surface Translocation Using Decoy Peptides: Identification of an Essential Role of the C-Terminus in Receptor Trafficking.

21. Contribution of Telomere Length to Systemic Sclerosis Onset: A Mendelian Randomization Study.

22. The Application of MicroRNAs in Glaucoma Research: A Bibliometric and Visualized Analysis.

23. Endothelial Dysfunction in Systemic Sclerosis.

24. Antibody Cross-Reactivity in Auto-Immune Diseases.

25. A Model of iPSC-Derived Macrophages with TNFAIP3 Overexpression Reveals the Peculiarities of TNFAIP3 Protein Expression and Function in Human Macrophages.

26. Skin Gene Expression Profiles in Systemic Sclerosis: From Clinical Stratification to Precision Medicine.

27. Repressive Control of Keratinocyte Cytoplasmic Inflammatory Signaling.

28. Surveying the Metabolic and Dysfunctional Profiles of T Cells and NK Cells in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

29. Resistin-like Molecule α and Pulmonary Vascular Remodeling: A Multi-Strain Murine Model of Antigen and Urban Ambient Particulate Matter Co-Exposure.

30. The Role of Autophagy and Apoptosis in Affected Skin and Lungs in Patients with Systemic Sclerosis.

31. Doubtful Clinical Value of Subtyping Anti-U1-RNP Antibodies Regarding the RNP-70 kDa Antigen in Sera of Patients with Systemic Lupus Erythematosus.

32. Systemic Blood Proteome Patterns Reflect Disease Phenotypes in Neovascular Age-Related Macular Degeneration.

33. Acute Exacerbations of Interstitial Lung Diseases: Focus on Biomarkers.

34. Mesenchymal Stem/Stromal Cell-Based Therapies in Systemic Rheumatic Disease: From Challenges to New Approaches for Overcoming Restrictions.

35. UBASH3A Interacts with PTPN22 to Regulate IL2 Expression and Risk for Type 1 Diabetes.

36. Role of Sex Hormones in Prevalent Kidney Diseases.

37. Targeting Protein–Protein Interfaces with Peptides: The Contribution of Chemical Combinatorial Peptide Library Approaches.

38. Enhancing Regulatory T Cells to Treat Inflammatory and Autoimmune Diseases.

39. Effects of the Oral Angiotensin II Type 2 Receptor Agonist C21 in Sugen-Hypoxia Induced Pulmonary Hypertension in Rats.

40. Endothelial Injury Syndromes after Allogeneic Hematopoietic Stem Cell Transplantation: Angiopetin-2 as a Novel Predictor of the Outcome and the Role of Functional Autoantibodies against Angiotensin II Type 1 and Endothelin A Receptor.

41. Allosteric Regulation of G-Protein-Coupled Receptors: From Diversity of Molecular Mechanisms to Multiple Allosteric Sites and Their Ligands.

42. Assessment of the Potential Role of Selected Single Nucleotide Polymorphisms (SNPs) of Genes Related to the Functioning of Regulatory T Cells in the Pathogenesis of Psoriasis.

43. Autoantibodies against PIP4K2B and AKT3 Are Associated with Skin and Lung Fibrosis in Patients with Systemic Sclerosis.

44. Systemic Lupus Erythematosus and Pulmonary Hypertension.

45. Serum Biomarkers in Connective Tissue Disease-Associated Pulmonary Arterial Hypertension.

46. Current Trends in Vascular Biomarkers for Systemic Sclerosis: A Narrative Review.

47. The Molecular Mechanisms of Systemic Sclerosis-Associated Lung Fibrosis.

48. CXCL4-RNA Complexes Circulate in Systemic Sclerosis and Amplify Inflammatory/Pro-Fibrotic Responses by Myeloid Dendritic Cells.

49. Unraveling the Link between Interferon-α and Systemic Lupus Erythematosus: From the Molecular Mechanisms to Target Therapies.

50. Are There Differences in Inflammatory and Fibrotic Pathways between IPAF, CTD-ILDs, and IIPs? A Single-Center Pilot Study.

Catalog

Books, media, physical & digital resources